CD44 and breast carcinoma: First we analyzed the Cancer Genome Atlas (TCGA) breast cancer cohort by single-sample gene set enrichment analysis (ssGSEA25), with a CD44+CD24− BCSC signature previously identified in human breast carcinomas26, and then the genes with expression highly correlated with the BCSC ssGSEA scores in the TCGA samples were selected.